Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Covington
Daiichi Sankyo
Accenture
Boehringer Ingelheim
Citi
Baxter
Colorcon
QuintilesIMS

Generated: February 18, 2019

DrugPatentWatch Database Preview

Sun Pharm Inds Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for SUN PHARM INDS LTD, and when can generic versions of SUN PHARM INDS LTD drugs launch?

SUN PHARM INDS LTD has one hundred and twenty-one approved drugs.

There are nine US patents protecting SUN PHARM INDS LTD drugs. There are two tentative approvals on SUN PHARM INDS LTD drugs.

There are forty-six patent family members on SUN PHARM INDS LTD drugs in twenty-three countries and one hundred and seventy-seven supplementary protection certificates in thirteen countries.

Summary for Sun Pharm Inds Ltd
International Patents:46
US Patents:9
Tradenames:94
Ingredients:91
NDAs:121

Drugs and US Patents for Sun Pharm Inds Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd RISPERIDONE risperidone TABLET, ORALLY DISINTEGRATING;ORAL 077542-001 Aug 6, 2010 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharm Inds Ltd CEPHALEXIN cephalexin FOR SUSPENSION;ORAL 065081-002 Jul 27, 2001 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharm Inds Ltd AMOXICILLIN AND CLAVULANATE POTASSIUM amoxicillin; clavulanate potassium TABLET;ORAL 065109-001 Nov 4, 2002 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharm Inds Ltd NEFAZODONE HYDROCHLORIDE nefazodone hydrochloride TABLET;ORAL 076409-003 Sep 16, 2003 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharm Inds Ltd RISPERIDONE risperidone TABLET, ORALLY DISINTEGRATING;ORAL 078464-004 Apr 8, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharm Inds Ltd INFUGEM gemcitabine hydrochloride SOLUTION;INTRAVENOUS 208313-006 Jul 16, 2018 RX Yes Yes 9,241,948 ➤ Try a Free Trial Y ➤ Try a Free Trial
Sun Pharm Inds Ltd RISPERIDONE risperidone TABLET, ORALLY DISINTEGRATING;ORAL 078464-003 Apr 8, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Sun Pharm Inds Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sun Pharm Inds Ltd XIMINO minocycline hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 201922-001 Jul 11, 2012 5,908,838 ➤ Try a Free Trial
Sun Pharm Inds Ltd XIMINO minocycline hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 201922-003 Jul 11, 2012 5,908,838 ➤ Try a Free Trial
Sun Pharm Inds Ltd XIMINO minocycline hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 201922-005 Jul 11, 2012 5,908,838 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for SUN PHARM INDS LTD drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
➤ Subscribe Injection 250 mcg/0.5 mL, 1 mL PFS ➤ Subscribe 2012-03-30

International Patents for Sun Pharm Inds Ltd Drugs

Supplementary Protection Certificates for Sun Pharm Inds Ltd Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
595 Luxembourg ➤ Try a Free Trial PRODUCT NAME: SIMEPREVIR, OU L UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES, INCLUANT SIMEPREVIR SODIUM. FIRST REGISTRATION: 20140516
9 5017-2014 Slovakia ➤ Try a Free Trial PRODUCT NAME: KOMBINACIA DAPAGLIFLOZINU ALEBO JEHO FARMACEUTICKY PRIJATELNYCH SOLI A METFORMINU ALEBO JEHO FARMACEUTICKY PRIJATELNYCH SOLI; REGISTRATION NO/DATE: EU/1/13/900/001 - EU/1/13/900/012 20140116
1730131/02 Switzerland ➤ Try a Free Trial PRODUCT NAME: EMPAGLIFLOZIN UND METFORMINHYDROCHLORID; REGISTRATION NO/DATE: SWISSMEDIC 65570 12.11.2015
14/032 Ireland ➤ Try a Free Trial PRODUCT NAME: DOLUTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, INCLUDING DOLUTEGRAVIR SODIUM; REGISTRATION NO/DATE: EU/1/13/892/001-002 20140121
C0038 Belgium ➤ Try a Free Trial PRODUCT NAME: RIVASTIGMINE; NAT. REGISTRATION NO/DATE: EU/1/98/066/001 19980512; FIRST REGISTRATION: CH 54275 01 19970731
12/048 Ireland ➤ Try a Free Trial PRODUCT NAME: A COMBINATION PRODUCT COMPRISING ASPIRIN AND ESOMEPRAZOLE MAGNESIUM TRIHYDRATE; NAT REGISTRATION NO/DATE: PA 970/063/001 20120831; FIRST REGISTRATION NO/DATE: 5402359; 5402367 5402375 20110812
00375 Netherlands ➤ Try a Free Trial PRODUCT NAME: COMBINATIE VAN OLMESARTAN MEDOXOMIL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT EN AMLODIPINEBESILAAT; REGISTRATION NO/DATE: RVG100984, RVG100986-87, RVG100989-91, RVG100993-95 20080819
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
McKesson
Colorcon
Johnson and Johnson
Mallinckrodt
McKinsey
Cerilliant
Julphar
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.